Search bioRxiv⌕ Search

Biology subjects

Jusoh, S. A.

Publications and source records attributed to Jusoh, S. A..

2 recordsLinked to original sources

Modeling of GyrA, MexB, FtsI, AtpD Protein Variants In Multidrug Resistant Acinetobacter baumannii

Acinetobacter baumannii is a Gram-negative nosocomial pathogen known to manifest numerous drug resistances against major antibiotic classes. Compounded by its pathogenicity and virulence, it is considered globally as a top priority threat among the ESKAPE pathogens. The GyrA, MexB, FtsI and AtpD proteins in A. baumannii strain PR07 have been proven to mutate under exposure to ciprofloxacin, meropenem, imipenem and erythromycin, respectively. While the genomic data is useful, the impact of the mutations on the protein structure and function is not well understood. To obtain a deeper understanding, the protein structures were analyzed using structural bioinformatics tools. Here, the PR07 GyrA, MexB, FtsI and AtpD protein sequence data from NCBI were compared between ESKAPE pathogens and other A. baumannii species. MexB and AtpD structures were retrieved from the PDB database, while AlphaFold was used to construct protein structure predictions for GyrA and FtsI. MSA analyses identified mutations GyrA S81L, MexB S181L, FtsI P508, FtsI A515V, FtsI A579T and AtpD A166V mutations to be unique among the selected bacteria species. The mutation sites for all four target proteins were found to be within proximity to the potential binding sites. GyrA S81L, MexB S181L, FtsI A515V and FtsI A579T rigid protein models have shown loss of inter-residue polar hydrogen bonds, while AtpD A166V caused no observable changes. The mutations reported in PR07 therefore may potentially be significant contributors to its acquired resistance towards the target antibiotics.

molecular biology↗

Structural Dynamics of LDL Receptor Interactions with E498A and R499G Variants of PCSK9

The low-density lipoprotein receptor (LDLR) plays an integral role in cellular cholesterol uptake and lipid metabolism by primarily regulating hepatic clearance of plasma low-density lipoprotein cholesterol (LDL-C). Physiologically, proprotein convertase subtilisin/kexin type-9 (PCSK9) attenuates LDLR function by binding to the LDLR extracellular domain, leading to its lysosomal degradation and thereby preventing the total depletion of circulating LDL-C. However, pathogenic variants of PCSK9 are able to reduce the availability of LDLR, thus significantly increasing plasma LDL-C levels. Despite this understanding, the detailed molecular mechanism of LDLR-PCSK9 interaction remains elusive due to the lack of a full atomistic structure of LDLR. In this study, molecular dynamics (MD) simulations were employed to predict LDLR structural dynamics upon binding to PCSK9. Furthermore, two PCSK9 variants, E498A and R499G that were identified in clinically diagnosed Malaysian FH patients were investigated for their mutational effects. The simulations, spanning 500 ns, were conducted for three LDLR-PCSK9 complexes: LDLR-PCSK9 wild-type (WT), LDLR-PCSK9 (E498A), and LDLR-PCSK9 (R499G). Throughout the simulations, PCSK9 structure remained highly stable, in contrast to the LDLR structure that sampled large conformational space. The WT complex exhibited the least change, whereas the R499G complex displayed the most pronounced conformational rearrangement. During the simulations of WT and E498A complexes, the {beta}-propeller domain of LDLR formed interactions with the prodomain of PCSK9. Aligned with the observation, the MM/GBSA analysis revealed that the E498A complex exhibited the highest LDLR-PCSK9 binding affinity (-63.81 kcal/mol), followed by the WT complex (-33.07 kcal/mol), and the R499G complex (-24.21 kcal/mol). These findings provide novel insights into the dynamic interactions between LDLR and PCSK9, highlighting the importance of structural flexibility in mediating their functional relationship. Further studies with complete LDLR structures are required to fully elucidate the molecular mechanisms underlying LDLR-PCSK9-mediated cholesterol homeostasis.

biophysics↗